本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
SHANGHAI, Aug. 11, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the ADC and broader bioconjugate market, and Boostimmune, a biotech company dedicated to developing next-generation anti-cancer therapies modulating the tumor immune microenvironment and ADCs to novel targets, today announced that they have signed a Memorandum of Understanding (MOU) for comprehensive, integrated discovery services for Boostimmune's pipeline. Under the collaboration, Boostimmune will have access to WuXi XDC's fully integrated, one-stop bioconjugate platform and extensive expertise in industry-leading discovery capabilities, with WuXi XDC providing end-to-end services to support Boostimmune's discovery of novel bioconjugates. Dr. Gwanghee Lee, Co-founder and CEO of Boostimmune, commented, "Boostimmune is focused on answering urgent unmet clinical needs and dedicated to providing patients around the world with high-quality, innovative therapies. Accessing WuXi XDC's leading bioconjugate platform and in-depth industry know-how will afford exciting opportunities for us to explore novel ADCs and other bioconjugates that could become transformative therapeutics." Dr. Jimmy Li, CEO of WuXi XDC, commented, "We look forward to supporting Boostimmune with our state-of-the-art conjugation technologies and high-quality services. Our fully integrated, one-stop platform will accelerate the ADC discovery timeline and enable Boostimmune to advance its innovative pipeline. As a global CRDMO, we aim to continually enhance our platform and help propel the growth of the bioconjugate industry for the benefit of patients worldwide." About Boostimmune Boostimmune is a biotech company developing innovative, first-in-class antibody-based therapies to address unmet needs in oncology. Its pipeline projects consist of naked monoclonal antibodies to modulate the tumor immune microenvironment, ADCs to novel targets with potential patient selection biomarkers and an ISAC (Immune Stimulator Antibody Conjugate) directly targeting immunosuppressive myeloid cells. Boostimmune was co-founded in 2021 by a world-class pioneering immunologist, Professor Tadatsugu Taniguchi at the University of Tokyo, who originally identified Interferon beta, Interleukin-2, and Interferon regulatory factors (IRFs). About WuXi XDC WuXi XDC is a leading global CRDMO focused on the ADC and broader bioconjugate market. It is a joint venture between WuXi Biologics and WuXi STA, providing end-to-end contract research, development and manufacturing services for bioconjugates, including antibody drug conjugates (ADCs). Its services cover antibodies and other biologics intermediates, chemical payloads and linkers, as well as bioconjugate drug substances and drug products. WuXi XDC has been successful in bringing multiple ADC projects to the Investigational New Drug(IND) filing stage in 15 months or less, nearly cutting in half the traditional development timeline. As of May 2023, 102 on-going integrated projects are under development at WuXi XDC, including 44 post-IND bioconjugate projects, among which 14 projects are in phase II/III. For more information about WuXi XDC, please visit: https://www.wuxibiologics.com/services-solutions/#XDC. Contacts Media PR@wuxibiologics.com Businessinfo@wuxibiologics.com
HONG KONG SAR - Media OutReach - 25 July 2023 - B Capital, a global multi-stage investment firm, today, announced that it has entered into a memorandum of understanding (MoU) with SAP to support growth and innovation for B Capital's portfolio companies in the Asia-Pacific region. Under the signed MoU, B Capital's portfolio companies will benefit from a joint go-to-market strategy (GTM) as well as access to SAP's global reach, resources, business networks and best practices. They will also be able to learn more about and evaluate SAP's suite of enterprise solutions, including fit-to-standard cloud offerings such as GROW with SAP, that are designed to help SMEs and start-ups scale quickly. The collaboration aims to offer B Capital's portfolio companies tailored, end-to-end support for their software solutions, helping progress them through development to being available for purchase on the SAP Store, an online marketplace of software solutions from SAP and its partners, available in more than 200 countries and territories globally. "We are thrilled to deepen our collaboration with SAP and look forward to providing our founders and portfolio companies with the support and resources to supercharge their growth and scale their businesses globally," said Arijit Sengupta, General Partner at B Capital. "This collaboration reaffirms our commitment to bridging the gap between today's industry leaders and tomorrow's emerging companies, especially in the Asia-Pacific region." "SAP's partner ecosystem is more important to SAP and our customers today than ever before, as we increasingly tap into partner innovation to accelerate cloud transformation, together," said Utkarsh Maheshwari, Chief Partner Officer, Asia Pacific Japan, SAP. "Our collaboration with B Capital connects us to start-up talents from its portfolio companies and injects new technology innovations that can be readily integrated into SAP environment through SAP Business Technology Platform. This opens up more opportunities for SAP customers and other partners as well, as we continue to build future-readiness, especially for the AI economy." B Capital and SAP have a longstanding relationship. Several of B Capital's portfolio companies, including Kopi Kenangan – Indonesia's fastest-growing coffee chain, have adopted SAP's solutions to improve enterprise resource planning (ERP) workflows and enhance experiences. The MoU reaffirms B Capital's and SAP's continued commitment to the Asia-Pacific region, a fast-growing hub for innovation. B Capital has been investing in the region since 2016, and SAP has been working with Asia-Pacific enterprises since 1989. Together, B Capital and SAP will support entrepreneurs as they launch cutting-edge technologies and expand their innovations to new markets and geographies. -END- SAP and SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices. All other product and service names mentioned are the trademarks of their respective companies. Hashtag: #BCapitalThe issuer is solely responsible for the content of this announcement.B CapitalB Capital is a multi-stage global investment firm that partners with extraordinary entrepreneurs to shape the future through technology. With more than $6 billion in assets under management across multiple funds, the firm focuses on seed to late-stage venture growth investments, primarily in the enterprise, financial technology and healthcare sectors. Founded in 2015, B Capital leverages an integrated team across nine locations in the US and Asia, as well as a strategic partnership with BCG, to provide the value-added support entrepreneurs need to scale fast and efficiently, expand into new markets and build exceptional companies. For more information, click here.
ProLogium and MAHLE will conduct cell tests for the development of innovative thermal management system. The two companies will enter into discussion on building a prototype of "ProLogium- MAHLE" solid-state battery pack. The joint efforts will contribute to the development of commercially viable solid-state battery solutions with enhanced safety, energy density and lifespan. TAIPEI, July 25, 2023 /PRNewswire/ -- ProLogium and MAHLE have signed an MOU for the development of the first thermal management system tailored for ProLogium's next generation solid-state batteries. The collaborative efforts will contribute to the rollout of commercially viable solid-state battery solutions that offer improved safety, energy density, and lifespan. Under the MoU, both parties will collaborate on cell tests focusing on thermal properties to facilitate the development of innovative thermal management for solid-state batteries. This is the first time MAHLE, a leading century-old automotive supplier, has tapped into the solid-state battery industry. After a series of evaluations on ProLogium's solid-state batteries with 100% SiOx anode, the two companies will enter into discussion regarding building prototypes for "ProLogium- MAHLE" solid-state cell modules and battery pack. "The shared goal that unifies ProLogium and MAHLE is to speed up clean transportation with innovations," said Vincent Yang, CEO and founder of ProLogium Technology. "We are also excited about potential collaborations in manufacturing and supply chain. The partnership between two pioneering companies in the next-generation battery and engineering fields signifies a leap forward in shaping a revolutionary battery value chain, which is crucial for advancing the industrialization of solid-state batteries." "The cooperation with ProLogium is an absolute win-win situation. With the combined expertise of the two groups, we will shape future battery technologies with superior properties", said Arnd Franz, Chairman of the MAHLE Management Board and CEO. ProLogium adopts oxide ceramic electrolytes, featuring higher heat conductivity and thermal stability. Therefore, the innovation necessitates a distinct approach to heat dissipation and thermal management in the design process. "A well-designed thermal management system is one of the keys to further strengthening ProLogium batteries' advantages in performance and lifespan. Leveraging MAHLE's deep expertise in developing advanced thermal management system, we look forward to creating EV battery solutions that provide increased energy density and chargeability while demonstrating excellent safety, stability and life performance," remarked Polun Cheng, Global Project Management AVP of ProLogium Technology. About MAHLE MAHLE is a leading international development partner and supplier to the automotive industry with customers in both passenger car and commercial vehicle sectors. Founded in 1920, the technology group is working on the climate-neutral mobility of tomorrow, with a focus on the strategic areas of electrification and thermal management as well as further technology fields to reduce CO2 emissions, such as fuel cells or highly efficient combustion engines that also run on hydrogen or synthetic fuels. Today, one in every two vehicles globally is equipped with MAHLE components. MAHLE generated sales of more than EUR 12 billion in 2022. The company is represented with approx. 72,000 employees at 152 production locations and 12 major research and development centers in more than 30 countries. (as of 31.12.2022) #weshapefuturemobility About ProLogium Founded in 2006, ProLogium is an energy innovation firm focused on the R&D and manufacturing of next-generation battery solutions for EV, consumer, and industrial applications. Its proprietary technologies cover more than 650 (applied and awarded) patents globally. ProLogium has demonstrated its commercial capabilities through its automated pilot production line, with which it has shipped nearly 8,000 solid-state battery sample cells to international automotive OEMs for testing and module development. Its first giga-scale production line in Taoyuan, Taiwan will start operations by the end of 2023, which will help accelerate the company's capacity expansion in major global markets.
CYBERJAYA, Malaysia, July 24, 2023 /PRNewswire/ -- The UAE Regulation Lab (RegLab), which is under the General Secretariat of the UAE Cabinet, has joined forces with the Futurise Sdn Bhd (Futurise), a Malaysian company under the purview of the Ministry of Finance, to create an agile and conducive legislative environment that pioneers regulation innovation. Rosihan Zain Baharudin, Chief Executive Officer of Futurise with H.E. Maryam Alhammadi, Minister of State and Secretary General of the UAE Cabinet. In a bid to form a pact to pave a strong foundation for the fast-tracking of new emerging solutions through regulatory sandboxes and other catalytic initiatives in Malaysia and the UAE, the new partners signed a memorandum of understanding (MoU) that will see the leveraging of each other's technical knowledge and experience at various levels. The MoU signing ceremony which was held in the UAE, saw the signing of the partnership agreement between H.E. Maryam Alhammadi, Minister of State and Secretary General of the UAE Cabinet and Mr. Rosihan Zain Baharudin, Chief Executive Officer of Futurise. Her Excellency Maryam Alhammadi, Minister of State and Secretary General of the UAE Cabinet said, "This Memorandum of Understanding will enable us to band together to discuss challenges, innovative approaches and ideas that will amplify our regulatory efforts and achieve global standards and benchmarks in creating a thriving regulatory innovation ecosystem which will truly transform the sector." Aside from active discussions around strategies to foster a conducive environment and enable functional and unhindered cultivation of new technologies for entrepreneurs and businesses in the two countries, the agreement also enables the coordination between both parties to explore cross-border collaboration and research and development (R&D) initiatives. Rosihan Zain Baharudin, Chief Executive Officer of Futurise said that the partnership marks a pivotal step forward in positively impacting both nation's innovation landscape. For Malaysia, this opens up moregov space for the future economy to grow under the framework of the New Investment Policy and the country's digital economy aspirations. "We are thrilled and honoured to be working hand-in-hand with UAE Regulations Lab to put in place all the building blocks essential to galvanise Malaysia's technological ecosystem. This will help us in refining a lot of our initiatives at Futurise and steer us in the right direction by looking at best practices in other nations. Our combined knowledge bank with UAE Regulations Lab will symbiotically build a strong foundational layer for both nations to tap into and open up endless possibilities for more dynamic innovative solutions to come to fruition." The partnership will also activate co-research activities on vital areas of common interest such as the design, development and management of regulatory sandbox programmes and open innovation platforms for numerous industries. This will drive the experimentation of regulatory solutions that can be replicated, localised and scaled for use depending on the needs of the ecosystem. The MoU signing ceremony was followed up with two RegTalk sessions participated by industry experts on various mobility topics organised by UAE Regulations Lab and Futurise. Stretched over three days, the visit to the UAE by the Malaysian delegates also featured meetings and networking sessions with ecosystem bodies within the UAE to provide access and exchange necessary to promote discussions and collaborations that will revolutionise the future of mobility. About Futurise Futurise is a wholly-owned subsidiary of Cyberview Sdn Bhd under the Ministry of Finance. Futurise is mandated by the Government of Malaysia to manage the National Regulatory Sandbox. Futurise provides public policy advisory, acting as a key enabler of regulatory solutions that can expedite innovation and future-proof Malaysia's economy. The NRS provides a forward-looking approach to regulation, allowing minimal barriers by creating a controlled regulatory testing environment. This initiative will also help the Government better understand the importance of the impact of technology on economic growth and human capital development based on the principle of 'data-driven policy intervention'. Follow Futurise social media for updates: FB: https://www.facebook.com/futurise.cyberjayaInstagram: https://www.instagram.com/futurisecyberjaya/?hl=enLinkedin: https://www.linkedin.com/company/futurise/Twitter: https://twitter.com/futurisecyber?lang=en
HONG KONG SAR - Media OutReach - 18 July 2023 - UMP Healthcare Innov Centre recently signed a memorandum of understanding (MOU) with the Israel Export and International Cooperation Institute (IEICI), witnessed by Head of Israel Economic and Commercial Mission in Hong Kong and Macau, to jointly promote Israeli scientific research and start-up companies in the medical and healthcare field in Hong Kong, and to seek cooperation opportunities in the fields of MedTech and HealthTech. At the same occasion, IEICI inked a collaboration pact with the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA) to foster tighter cooperation between Hong Kong and Israeli enterprises. Ronnie LI, Director at UMP Healthcare Innov Centre, delivered his remarks With an ageing population and increased need for medical professionals, the tendency is to create medical technology to relieve the strain on human resources. The parties will collaborate to promote medical technology and healthcare products, seek potential investors for medical technology and products, jointly organise and participate in various forum activities, provide consulting services for start-up companies, and so on, according to the framework established by the memorandum. "I am very pleased to sign a memorandum of cooperation with IEICI," said Ronnie LI, Director at UMP Healthcare Innov Centre. "UMP Healthcare Group has continuously invested in medical equipment as well as cutting-edge scientific research and products. UMP Healthcare Innov Centre, Hong Kong's first permanent exhibition platform for MedTech, actively seeks suitable instruments to apply to the Group's services. We are extremely honoured to be able to partner with IEICI and HKMHDIA to jointly promote public and industry peers' awareness of Israel's high-tech goods and innovations, as well as to foster professionalism between Hong Kong and Israel." Group photo after signing MOU with UMP Healthcare Innov Centre, HKMHDIA and IEICI Over the past few decades, Israel has established itself as one of the most technologically advanced countries in the world. With ranking first in the world for R&D expenditure as a share of GDP, the highest number of startups per capita, and advanced technological capabilities across a vast range of sectors. Healthcare is currently the largest sector in the Israeli startup ecosystem, representing about 20% of all technology companies, with over 1,600 active startup companies developing cutting-edge technologies to address a wide range of health challenges. These include digital health solutions, medical devices, drug development, and more. "We are very excited to sign the MOU," stated Mrs. Nili SHALEV, Chief Executive Officer of IEICI. "I believe this collaboration can help to strengthen ties between Hong Kong and Israel, and allow healthcare enterprises and startups of both places to work together more closely, by cooperating on research and development initiatives, combining resources and skills, generating innovative goods and technologies, and offering the most recent investment prospects to the industry and adjacent areas." Dr. Lydia LEUNG, Chairlady of HKMHDIA, commented, "HKMHDIA's annual theme this year is to establish Hong Kong as International MedTecHub. The signing of the memorandum with Israel today is an important milestone, which is of special significance to us. Not only will we strive to promote knowledge exchange among medical professionals in Israel, Hong Kong and Mainland China, we expect that the technology and products of both parties can be promoted to the Greater Bay Area, Mainland China and the international market to achieve a win-win situation." Hashtag: #UMPHealthcareInnovCentre The issuer is solely responsible for the content of this announcement.About UMP Healthcare Holdings LimitedFounded in 1990, UMP Healthcare is a medical group listed on the Main Board of the Hong Kong Stock Exchange (stock code 722.HK) and is one of the leading comprehensive healthcare service platforms in the Hong Kong market. We have been committed "To provide comprehensive, diversified and coordinated care for everyone" by creating a network of high-quality and effective medical services for patients, payers, providers and partners. Along with providing healthcare services that address a wide range of individual needs, UMP Healthcare closely works with more than 2,000 local and international businesses and insurance organisations to establish and administer corporate healthcare benefit programs for members. The medical service network spans over 1,000 self-owned and affiliated institutions across Hong Kong, Macau, and Mainland China, offering services such as family medicine, specialist consultation, dental care, diagnostic imaging and laboratory testing, preventive medicine and health examination, physical therapy, day surgery, and endoscopy, among others. www.ump.com.hk
SINGAPORE and DUBAI, UAE, July 13, 2023 /PRNewswire/ -- ACX (formerly known as AirCarbon Exchange), operating its proprietary regulated environmental asset trading platform that is revolutionising the environmental markets, has signed a Memorandum of Understanding with Blue Carbon, the Dubai-based project developer, to develop carbon markets in the Middle East and North Africa region. The collaboration will see Blue Carbon using ACX as its preferred platform to sell its carbon credits and settle transactions. The two companies will also seek to host auctions to sell Blue Carbon's credits in the run up to the COP28 climate conference in Dubai. In addition, they will assist one another in developing suitable market infrastructure to enable the UAE and partner countries to implement Article 6.2 transactions under the United Nations' Paris Agreement. William Pazos, Co-CEO and Co-Founder of ACX, said, "We are delighted to partner with Blue Carbon as their preferred platform for selling carbon credits and facilitating seamless transactions. Cooperation is central to our fight against climate change. Our agreement today is a great example of how companies can join forces to leverage each other's strengths to create opportunities and results." This MOU is another step in ACX's journey to become the leading global carbon exchange. With the successful establishment of the world's first regulated carbon exchange in Abu Dhabi, ACX is making significant strides in positioning itself as a major player in the carbon trading landscape, in the MENA region and on a global scale. Blue Carbon is developing projects that will be eligible for carbon credits or Internationally Transferred Mitigation Outcomes (ITMO), which count towards a country's Nationally Determined Contributions (NDCs). This sector is likely to grow in popularity as countries rich in carbon resources seek to sell their credits to heavy emitting countries. Josiane Sadaka, CEO of Blue Carbon commented on the crucial use of ITMOs in combatting climate change, said, "ITMOs are a powerful tool for global cooperation. They address the urgent need for collective action towards a sustainable and resilient future. By embracing this collaborative approach, we forge a path towards a low-carbon future that benefits both humanity and the environment." By closely aligning all activities with the UN's Article 6 framework, ACX's work is also plotting a pathway for the voluntary and compliance carbon sectors to line up in the coming years. About the ACX Group: The ACX (formerly AirCarbon Exchange) Group, including ACX Ltd and AirCarbon Pte. Ltd. which operate environmental exchanges in Abu Dhabi and Singapore respectively, caters to corporate entities, financial traders, carbon project developers and other industry stakeholders. ACX provides participants with an efficient and transparent trading platform that is user-friendly, seamless and offers the lowest transaction fees in the market. Leveraging distributed ledger technology, ACX facilitates the scalable growth of the environmental product markets to align with global ambitions of achieving Net Zero. ACX is proud to be a member of the International Emissions Trading Association (IETA) and the International Sustainability and Carbon Certification (ISCC), further enhancing its commitment to sustainability and responsible trading practices for carbon and other environmental products. ACX has garnered international recognition as the Best Carbon Exchange globally in Environmental Finance's esteemed Voluntary Carbon Market Rankings for two consecutive years (2021, 2022), solidifying its position as a leader in the industry. For more information, please contact info@acx.net or visit www.acx.net. About Blue Carbon: Blue Carbon deploys emerging strategies to support country's efforts to decarbonize by using only methodologies that focus on compliance markets. The company is committed to helping businesses and government utilities define their sustainable frameworks to help transition to a low carbon economy and reach their Net Zero goals in compliance with the transferability of credits under Article 6 of the Paris Agreement. Blue Carbon helps accelerate sustainable development through strategic investments as well as fostering environmental economic development and advancing sustainability through its bilateral relationships. The company's vast industry experience allows it to benchmark data and drive economic opportunities and growth for its stakeholders. For more information, visit https://bluecarbon.ae/
A12 藝術空間
MOU
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
